Publications

Publication list

Quick Links:  2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008

 

Projects initiated by the McGill sarcoma team are identified with a *

 

2024

 

  1. *Groszman, L.; Hubermann, J.A.; Kooner, P.; Alamiri, N.; Bozzo, A.; Aoude, A. The Impact of Adjunct Medical Therapy on Survival after Spine Metastasis: A Systematic Review and Pooled Data Analysis. Cancers 2024, 16, 1425. https:// doi.org/10.3390/cancers16071425
  2. Paruthikunnan S, Gorelik N, Turcotte RE, Jung S, Alcindor T, Powell TI. Clinical impact of whole-body MRI in staging and surveillance of patients with myxoid liposarcoma: a 14-year single-centre retrospective study. Eur Radiol. 2024 Apr 18. doi: 10.1007/s00330-024-10752-1. Epub ahead of print. PMID: 38637427
  3. Noujaim J, Gupta AA, Holloway CL, Saleh R, Srikanthan A, Lemieux C, Soroka HP, Tibout P, Turcotte R, Feng X, Abdul Razak AR, Costa P. Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study. Eur J Cancer. 2024 May 14;205:114119. doi: 10.1016/j.ejca.2024.114119. Epub ahead of print. PMID: 38759389
  4. *Bozzo A, Tsui JMG, Bhatnagar S, Forsberg J. Deep Learning and Multimodal Artificial Intelligence in Orthopaedic Surgery. J Am Acad Orthop Surg. 2024 Jun 1;32(11):e523-e532. doi: 10.5435/JAAOS-D-23-00831. Epub 2024 Apr 17. PMID: 38652882; PMCID: PMC11075751

 

2023

 

  1. *Rizkallah M, Araneta KT, Aoude A, Turcotte R. Outcomes After Abductor Reattachment to Proximal Femur Endoprosthesis After Tumor Resection. J Am Acad Orthop Surg. 2023 Jan 1;31(1):34-40. doi: 10.5435/JAAOS-D-22-00369. PMID: 36548152.
  2. Jordan J. Levett, Robert E. Turcotte, Sungmi Jung, John Antoniou, Olga L. Huk,
    Osteosarcoma Around a Ceramic-on-Ceramic Total Hip Arthroplasty,
    Arthroplasty Today, Volume 19, 2023, 101094, ISSN 2352-3441, https://doi.org/10.1016/j.artd.2022.101094.
  3. *Hassani M, Jung S, Ghodsi E, Seddigh L, Kooner P, Aoude A, Turcotte R. Value of Cellular Components and Focal Dedifferentiation to Predict the Risk of Metastasis in a Benign-Appearing Extra-Meningeal Solitary Fibrous Tumor: An Original Series from a Tertiary Sarcoma Center. Cancers. 2023; 15(5):1441. https://doi.org/10.3390/cancers15051441
  4. *Kooner P, Bozzo I, Rizkallah M, Hassani M, Turcotte RE, Aoude A. Primary Sarcomas of the Spine: A Systematic Review and Pooled Data Analysis. Clin Spine Surg. 2023 Feb 20. doi: 10.1097/BSD.0000000000001432. Epub ahead of print. PMID: 36823708.
  5. Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D’Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. PMID: 36884323.
  6. *Aoude A, Nikomarov D, Perera JR, Ibe IK, Griffin AM, Tsoi KM, Ferguson PC, Wunder JS. Giant cell tumour of bone. Bone Joint J. 2023 May 1;105-B(5):559-567. doi: 10.1302/0301-620X.105B5.BJJ-2022-1231.R1. PMID: 37121582.
  7. *Groszman, L., Nooh, A., Bernstein, M. et al. The Ilizarov Method for the Management of Bone Tumors in the Lower Extremity: Techniques, Indications, and Outcomes. SN Compr. Clin. Med. 5, 139 (2023). https://doi.org/10.1007/s42399-023-01477-1
  8. *Hassani, M, Mate, KKV, Turcotte, R, et al. Uncovering the gaps: a systematic mixed studies review of quality of life measures in extremity soft tissue sarcoma. J Surg Oncol. 2023; 128: 430–437. doi:10.1002/jso.27390
  9. *Košir, U., van de Wal, D., Husson, O. Zablith, N. Turcotte, R. Patient-physician agreement on function and pain is associated with long-term outcomes in sarcoma: findings from a longitudinal study. J Cancer Surviv (2023). https://doi.org/10.1007/s11764-023-01473-3
  10. *Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V.S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes, Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS), Radiotherapy and Oncology, Volume 190, 2024, 109935, ISSN 0167-8140, https://doi.org/10.1016/j.radonc.2023.109935
  11. Safavi AH, Freeman C, Cheng S, Patel S, Mitera G, Kundapur V, Rutledge R, Tsang DS. Proton Therapy in Canada: Toward Universal Access and Health Equity With a Publicly Funded Facility. Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):394-403. doi: 10.1016/j.ijrobp.2022.12.021. Epub 2022 Dec 21. PMID: 36565727
  12. Wang D, Harris J, Kraybill WG, et al. Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. JAMA Oncol. 2023;9(5):646–655. doi:10.1001/jamaoncol.2023.0042
  13. *Corn S, Nessim C, Roland CL, Gronchi A, Freeman C, Dumitra S. Data Dissemination of the Role of Neoadjuvant Radiation in Retroperitoneal Sarcoma: A CTOS and CSSO Survey. Curr Oncol. 2023 Jun 14;30(6):5807-5815. doi: 10.3390/curroncol30060434. PMID: 37366917; PMCID: PMC10296806.
  14. *Di Lalla V, Tolba M, Khosrow-Khavar F, Baig A, Freeman C, Panet-Raymond V. Radiation-Induced Sarcomas of the Breast: A Review of a 20-Year Single-Center Experience. Cureus. 2023 Apr 25;15(4):e38096. doi: 10.7759/cureus.38096. PMID: 37252471; PMCID: PMC10210072.
  15. Veng JH, Serban M, Renaud M-A, Freeman C, Seuntjens J. Robust mixed electron-photon radiation therapy planning for soft tissue sarcoma. Med Phys. 202350(10):6502-6513. doi: 10.1002/mp.16709. Epub 2023 Sep 8.PMID: 37681990.
  16. *Rizkallah M, Fabbri N, Turcotte R. Adamantinome. EMC – RADIOLOGIE ET IMAGERIE MÉDICALE : Musculosquelettique – Neurologique – Maxillofaciale 2023:1-9 [Article 31-521-A-10].
  17. Andersen NJ, Mate KKB, Bergeron C, Turcotte R, Körner A. Evaluating health perceptions of soft-tissue sarcoma patients using the Wilson-Cleary Model to identify key targets for improving outcomes and quality of care. Surg Oncol. 2023 Dec 15;52:102028. doi: 10.1016/j.suronc.2023.102028. Epub ahead of print. PMID: 38150784.
  18. *Rizkallah, M., Habra, N., Glavas, P., Turcotte, R. (2023). Femoral Osseointegration in a Transfemoral Amputee After Lengthening of Her Short Femoral Stump. In: Rozbruch, S.R., Hamdy, R. (eds) Limb Lengthening and Reconstruction Surgery Case Atlas. Springer, Cham. https://doi.org/10.1007/978-3-319-02767-8_450-1
  19. Levett JJ, Turcotte RE, Jung S, Antoniou J, Huk OL. Osteosarcoma Around a Ceramic-on-Ceramic Total Hip Arthroplasty. Arthroplast Today. 2023 Jan 21;19:101094. doi: 10.1016/j.artd.2022.101094. eCollection 2023 Feb.
  20. *Gorelik N, Paruthikunnan S, Uppal A, Ervin AM, Ramanakumar AV, Quaiattini A, Brophy JM, Gyftopoulos S. Usefulness of MRI-Based Local Surveillance After Surgical Treatment of Musculoskeletal Soft-Tissue Sarcomas: A Systematic Review and Meta-Analysis. American Journal of Roentgenology. 2023 Jun;220(6):805-816. doi: 10.2214/AJR.22.28865
  21. *Gorelik N, Rula EY, Pelzl CE, Hemingway J, Christensen EW, Brophy JM, Gyftopoulos S. Imaging Utilization Patterns in the Follow-Up of Extremity Soft Tissue Sarcomas in the United States. Current Problems in Diagnostic Radiology. 2023 Sep-Oct;52(5):357-366. doi: 10.1067/j.cpradiol.2023.05.002
  22. Bozzo, A., Yeung, C. M., Van De Sande, M., Ghert, M., Healey, J. H., & PARITY Investigators. (2023). Operative treatment and outcomes of pediatric patients with an extremity bone tumor: a secondary analysis of the PARITY Trial data. JBJS, 105(Suppl 1), 65-72.
  23. Heng VJ, Serban M, Renaud MA, Freeman C, Seuntjens J. Robust mixed electron-photon radiation therapy planning for soft tissue sarcoma. Med Phys. 2023 Oct;50(10):6502-6513. doi: 10.1002/mp.16709. Epub 2023 Sep 8. PMID: 37681990
  24. *Cury FL, Viani GA, Gouveia AG, Freire CVS, Grisi GA, Moraes FY. Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS). Radiother Oncol. 2024 Jan;190:109935. doi: 10.1016/j.radonc.2023.109935. Epub 2023 Oct 25. PMID: 37884194 Review.
  25. Martinez, C., Asso, R. N., Rastogi, N., Freeman, C. R., & Cury, F. L. (2024). Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapy. Radiotherapy and Oncology, 195, 110239.
  26. Al-Jazrawe M, Xu S, Poon R, Wei Q, Przybyl J, Varma S, van de Rijn M, Alman B. CD142 identifies neoplastic desmoid tumor cells, uncovering interactions between neoplastic and stromal cells that drive proliferation. Cancer Research Communications. 2023, 3 (4), 697-708

 

 

2022

 

  1. The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. Published online January 06, 2022. doi:10.1001/jamaoncol.2021.6628
  2. Przybyl J, Spans L, Ganjoo K, Bui N, Mohler D, Norton J, et al. (2022) Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma. PLoS ONE 17(1): e0262272. https://doi.org/10.1371/journal.pone.0262272
  3. *Panet F, Jung S, Alcindor T. Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion. JCO Precis Oncol. 2022 Jan;6:e2100303. doi: 10.1200/PO.21.00303. PMID: 35050712; PMCID: PMC8789206
  4. *Araneta KTS, Rizkallah M, Boucher LM, Turcotte R, Aoude A, (2022) Joint-sparing reconstruction for extensive periacetabular metastases: Literature review and a novel minimally invasive surgical technique, Journal of Bone Oncology, Volume 34,100428, ISSN 2212-1374, https://doi.org/10.1016/j.jbo.2022.100428.
  5. Sarre-Lazcano C, Dumitra S, Fiore M, (2022), Pelvic soft tissue sarcomas, European Journal of Surgical Oncology, ISSN 0748-7983, https://doi.org/10.1016/j.ejso.2022.06.003
  6. Baia M, Ford SJ, Dumitra S, Samà L, Naumann DN, Spolverato G, Callegaro D, (2022), Follow-up of patients with retroperitoneal sarcoma, European Journal of Surgical Oncology, ISSN 0748-7983, https://doi.org/10.1016/j.ejso.2022.02.016
  7. J.R. Perera, M. AlFaraidy, I. Ibe et al., (2022) Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy, European Journal of Surgical Oncology, https://doi.org/10.1016/j.ejso.2022.09.008
  8. Rizkallah M, Ferguson PC, Basile G, Kim P, Werier J, Wilson D, Turcotte R. LUMiC® endoprosthesis for pelvic reconstruction: A Canadian experience. J Surg Oncol. 2022 Dec 22. doi: 10.1002/jso.27181. Epub ahead of print. PMID: 36547873.
  9. Alaseem AM, Turcotte RE, Ste-Marie N, Alzahrani MM, Alqahtani SM, Goulding KA. Occupational injuries and burn out among orthopedic oncology surgeons. World J Orthop. 2022 Dec 18;13(12):1056-1063. doi: 10.5312/wjo.v13.i12.1056. PMID: 36567863; PMCID: PMC9782546.

 

 

2021

 

  1. *Tayara B, Nooh A, Chalopin A, Goulding K, Turcotte RE. Outcomes of Cemented Distal Femoral Replacement Using “Line to Line” Technique With All-Polyethylene Tibial Implant for Tumors. J Arthroplasty. 2021 Mar 18:S0883-5403(21)00283-7. doi: 10.1016/j.arth.2021.03.033. Epub ahead of print. PMID: 33840535.

  2. Bozzo A, Deng J, Abbas U, Bhasin R, Deodat M, Wariach S, Sanger S, Axelrod D, Masrouha K, Turcotte R, Wilson D, Ghert M. Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis. Clin Orthop Relat Res. 2021 Apr 7. doi: 10.1097/CORR.0000000000001749. Epub ahead of print. PMID: 33835092.

  3. *Hassani, M., Jung, S., Garzia, L. et al. Aggressive Behavior Predictors in Solitary Fibrous Tumor: Demographic, Clinical, and Histopathologic Characteristics of 81 Cases. Ann Surg Oncol (2021). https://doi.org/10.1245/s10434-021-09592-w
  4. Bunzli S, O’Brien P, Aston W, Ayerza MA, Chan L, Cherix S, de Las Heras J, Donati D, Eyesan U, Fabbri N, Ghert M, Hilton T, Idowu OK, Imanishi J, Puri A, Rose P, Sabah D, Turcotte R, Weber K, Dowsey MM, Choong PFM. Life or limb: an international qualitative study on decision making in sarcoma surgery during the COVID-19 pandemic..BMJ Open. 2021 Sep 2;11(9):e047175. doi: 10.1136/bmjopen-2020-047175.PMID: 34475158 Free PMC article.
  5. *Malagón T, Yong JHE, Tope P, Miller WH Jr, Franco EL; McGill Task Force on the Impact of COVID-19 on Cancer Control and Care. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Int J Cancer. 2021 Nov 29. doi: 10.1002/ijc.33884. Epub ahead of print. PMID: 34843106.
  6. *Rizkallah M, Aoude A, Turcotte R. Les métastases osseuses. Profession Santé, 2021 Nov, 43-47.
  7. Van De Sande M, Tap WD, Gelhorn HL, Ye X, Speck RM, Palmerini E, Stacchiotti S, Desai J, Wagner AJ, Alcindor T, Ganjoo K, Martín-Broto J, Wang Q, Shuster D, Gelderblom H, Healey JH. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. Acta Orthop. 2021 Aug;92(4):493-499. doi: 10.1080/17453674.2021.1922161. Epub 2021 May 12.PMID: 33977825 Free PMC article. Clinical Trial.
  8. Dalisson B, Charbonnier B, Aoude A, Gilardino M, Harvey E, Makhoul N, Barralet, Skeletal regeneration for segmental bone loss: Vascularised grafts, analogues and surrogates. J.Acta Biomater. 2021 Dec;136:37-55. doi: 10.1016/j.actbio.2021.09.053. Epub 2021 Oct 7.PMID: 34626818 Review.
  9. Lex JR, Koucheki R, Stavropoulos NA, Michele JD, Toor JS, Tsoi K, Ferguson PC, Turcotte RE, Papagelopoulos PJ. Megaprosthesis anti-bacterial coatings: A comprehensive translational review. Acta Biomater. 2021 Dec 5:S1742-7061(21)00794-7. doi: 10.1016/j.actbio.2021.11.045. Online ahead of print.PMID: 34879295 Review.
  10. *Alcindor T, Dumitra S, Albritton K, Thomas DM. Disparities in Cancer Care: The Example of Sarcoma-In Search of Solutions for a Global Issue. Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-7. doi: 10.1200/EDBK_320463. PMID: 33770458.
  11. COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5. PMID: 34624250; PMCID: PMC8492020.
  12. *Elkrief A, Kazandjian S, Alcindor T. Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series. Curr Oncol. 2021 Feb 5;28(1):813-817. doi: 10.3390/curroncol28010078. PMID: 33562486; PMCID: PMC7985763.
  13. *Alcindor T, Jung S, Gilbert L. Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report. Curr Oncol. 2021 Jun 10;28(3):2146-2149. doi: 10.3390/curroncol28030199. PMID: 34200874; PMCID: PMC8293099.

 

2020

 

  1. *Khazaei S, De Jay N, Deshmukh S, Hendrikse LD, Jawhar W, Chen CC, Mikael LG, Faury D, Marchione DM, Lanoix J, Bonneil E, Ishii T, Jain SU, Rossokhata K, Sihota TS, Eveleigh R, Lisi V, Harutyunyan AS, Jung S, Karamchandani J, Dickson BC, Turcotte R, Wunder JS, Thibault P, Lewis PW, Garcia BA, Mack SC, Taylor MD, Garzia L, Kleinman CL, Jabado N. H3.3G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in Giant Cell Tumour of Bone. Cancer Discov. 2020 Sep 23:CD-20-0461. doi: 10.1158/2159-8290.CD-20-0461. Online ahead of print.PMID: 32967858
  2. *Al Farii H, Frazer A, Farahdel L, AlFayyadh F, Turcotte R. Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials. J Am Acad Orthop Surg Glob Res Rev. 2020 Aug;4(8):e2000045. doi: 10.5435/JAAOSGlobal-D-20-00045.PMID: 32769706
  3. *Al Farii H; Doyle-Kelly C; Marwan Y; Volesky M; Turcotte R. Arthroscopic Management of Synovial Chondromatosis of the Ankle Joint: A systematic review of the literature. JBJS REVIEWS 2020;8(9):e20.00045 · http://dx.doi.org/10.2106/JBJS.RVW.20.00045
  4. *Ge, S.M., Marwan Y., Abduljabbar, F.H., Ge SM, Marwan Y, Abduljabbar FH, Morelli M, Turcotte RE. Arthroscopic management of intra- and juxta-articular osteoid osteoma of the upper extremity: a systematic review of the literature. Eur J Orthop Surg Traumatol (2020). https://doi.org/10.1007/s00590-020-02710
  5. *Al Aqeel M, Ricard MA, Al Farii H, Jung S, Turcotte R. Dedifferentiated Chondrosarcoma with Epithelial Differentiation: A Case Report and Review of the literature. (accepted Journal of Surgical Oncology Apr 2020)
  6. *Nooh A, Goulding K, Turcotte RE, Radiographical, Functional and Oncological Outcomes of Cemented Modular Proximal Femur Replacement using the “French Paradox” Technique. J Arthroplasty. 2020 Sep;35(9):2567-2572. doi: 10.1016/j.arth.2020.04.047. Epub 2020 Apr 23.
  7. *David Slawaska-Eng, Motaz AlAqeel, Humaid Al Farii, Cyril Boulila, Abdulrahman AlAseem, Robert Turcotte. Intraprosthetic Polyethylene Liner Dislocation of a Dual Mobility Mega-Prosthesis in an Osteosarcoma Patient: A Case Report and Literature Review. J Orthop Oncol 2020, 6:1
  8. *N, Mourad SA, Turpin S, Turcotte RE, Mitchell DA, Lambert R.Case Report 18F-FDG PET/CT of Pseudomyogenic Hemangioendothelioma. Plouznikoff Clin Nucl Med. 2020 Feb 27. doi: 10.1097/RLU.0000000000002973. [Epub ahead of print] PMID: 32108703
  9. *Kosir U, Denis‐Larocque G, Tsimicalis A, Freeman C, Turcotte RE, Cury F, Alcindor T, Goulding K.. Psychological functioning, coping styles and their relationship to appraisal of physical limitations following invasive surgical procedures for soft‐tissue sarcoma: A qualitative study. J Surg Oncol. 2020;1–10. https://doi.org/10.1002/jso.25915
  10. *DGCR8 microprocessor defect characterizes familial multinodular goiter with chwannomatosis. Rivera B, Nadaf J, Fahiminiya S, Apellaniz-Ruiz M, Saskin A, Chong AS, Sharma S, Wagener R, Revil T, Condello V, Harra Z, Hamel N, Sabbaghian N, Muchantef K, Thomas C, de Kock L, Hébert-Blouin MN, Bassenden AV, Rabenstein H, Mete O, Paschke R, Pusztaszeri MP, Paulus W, Berghuis A, Ragoussis J, Nikiforov YE, Siebert R, Albrecht S, Turcotte R, Hasselblatt M, Fabian MR, Foulkes WD. J Clin Invest. 2020 Mar 2;130(3):1479-1490
  11. Heng M1, Gupta A2, Chung PW3, Healey JH4, Vaynrub M4, Rose PS5, Houdek MT5, Lin PP6, Bishop AJ7, Hornicek FJ8, Chen YL9, Lozano-Calderon S9, Holt GE10, Han I11, Biau D12, Niu X13, Bernthal NM9, Ferguson PC14, Wunder JS14; Japanese Musculoskeletal Oncology Group (JMOG)15; Soft Tissue Osteosarcoma International Collaborative (STOIC). (Turcotte R collaborator). The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Eur J Cancer. 2020 Jan;125:130-141. doi: 10.1016/j.ejca.2019.07.029
  12. *Gorelik N, Hoda A, Liu C, Petchprapa C, Adler R. Human T-Cell Lymphotropic Virus Type-1 Associated Lymphoma Presenting as an Intramuscular Mass of the Calf. Skeletal Radiology. 2020;49(7):1167-1174.

 

2019

  1. Tap WD, Gelderblom H, Desai J, Bauer J, Blay JY; Alcindor T, Ganjoo K, Martín-Broto J, Thomas DM, Peterfy C, van de Sande M, Gelhorn HL, Shuster DE, Wang Q, Yver A, Hsu HH, Lin PS, Tong-Starksen S, Stacchiotti S, Wagner AJ. Pexidartinib for advanced tenosynovial giant cell tumor: results of the randomized phase 3 ENLIVEN study. The Lancet. 2019 Jun 19. pii: S0140-6736(19)30764-0. doi: 10.1016/S0140-6736(19)30764-0. [Epub ahead of print]
  2. Heng M, Gupta A, Chung PW, Healey JH, Vaynrub M, Rose PS, Houdek MT, Lin PP, Bishop AJ, Hornicek FJ, Chen YL, Lozano-Calderon S, Holt GE, Han I, Biau D, Niu X, Bernthal NM, Ferguson PC, Wunder JS; Japanese Musculoskeletal Oncology Group (JMOG); The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Soft Tissue Osteosarcoma International Collaborative (STOIC). Eur J Cancer. 2020 Jan;125:130-141. doi: 10.1016/j.ejca.2019.07.029. Epub 2019 Dec 2. (Turcotte R collaborator).
  3. Rivera B, Nadaf J, Fahiminiya S, Apellaniz-Ruiz M, Saskin A, Chong AS, Sharma S, Wagener R, Revil T, Condello V, Harra Z, Hamel N, Sabbaghian N, Muchantef K, Thomas C, de Kock L, Hébert-Blouin MN, Bassenden AV, Rabenstein H, Mete O, Paschke R, Pusztaszeri MP, Paulus W, Berghuis A, Ragoussis J, Nikiforov YE, Siebert R, Albrecht S, Turcotte R, Hasselblatt M, Fabian MR, Foulkes WD. DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.. J Clin Invest. 2019
  4. The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial. The SAFETY Investigators: Michelle Ghert, Mohit Bhandari,); Anthony Bozzo,); PD Sander Dijkstra; Anthony Griffin, Robert Grimer, James Hayden, Arlene Manherz; Karim Masrouha, Paula McKay, Benjamin Miller, Naveen Parasu, R Lor Randall, Patricia Schneider, Sheila Sprague, Lehana Thabane, Robert Turcotte, Roberto Vélez, David Wilson, Kevin Zbuk, Gordon Guyatt. BMJ Open 2019;9:e029054. doi:10.1136/ bmjopen-2019-029054.
  5. *Abuhejleh H, Wunder JS, Ferguson PC, Isler MH, Mottard S, Werier JA, Griffin AM, Turcotte RE. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius. Eur J Orthop Surg Traumatol. 2019 Jul 11. doi: 10.1007/s00590-019-02496-2. [Epub ahead of print]
  6. *Nooh NH, Al Aqueel M, Wang C, Turcotte RE Extraosseous Aneurysmal Bone Cyst in patient over 40 years old: Case Report and Review of The Literature.(Accepted JBJS Case Connector June 2019) D-18-00493R3
  7. Piscione J, Barden BScPT W, Barry J, Malkin A, Roy T, Sueyoshi T, Mazil K, Salomon S, Dandachli F, Griffin A, Saint-Yves H, Giuliano P, Gupta A, Ferguson P, Scheinemann K, Ghert M, Turcotte RE, Lafay-Cousin L, Werier J, Strahlendorf C, Isler M, Mottard S, Afzal S, Anderson ME, Hopyan S. The Pediatric Toronto Extremity Salvage Score (pTESS): Validation of a Self-reported Functional Outcomes Tool for Children with Extremity Tumors. Clin Orthop Relat Res. 2019Apr 27. doi: 0.1097/CORR.0000000000000756. [Epub ahead of print]
  8. *Al Farii H, Zhou S, Turcotte R. The Surgical Outcome and Recurrence Rate of Tenosynovial Giant Cell Tumor in the elbow: A Literature Review. J Shoulder Elbow Surg. 2019,. 28(9), 1835-1840.
  9. *Ge SM, Marwan Y, Addar A, Algarni N, Chaytor R, Turcotte RE. Arthroscopic Management of Osteoid Osteoma of the Ankle Joint: A Systematic Review of the Literature. J Foot Ankle Surg. 2019 May;58(3):550-554Ge SM, Marwan Y, Addar A, Algarni N, Chaytor R, Turcotte RE

 

2018

  1. Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N. Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO). Oncologist. 2018 Aug;23(8):948-955. doi: 10.1634/theoncologist.2017-0136. Epub 2018 Jun 22.
  2. *Alraiyes TM, Stavropoulos NA, Alaseem A, Jung S, Turcotte RE. Periosteal aneurysmal bone cyst. Lancet Oncol. 2018 Apr;19(4)
  3. * Kyle Raasck, Humaid Al Farii, Naser Alnusif, Xinyu Wang, Casey Wang, Ahmed Aoude, Krista Goulding and Robert Turcotte The Effects of Simultaneous Versus Staged Bilateral Femoral Intramedullary Nailing for Metastatic Disease on Survival Time and Perioperative Complications: A Systematic Review. J Orthop Oncol 2018, 4: 125
  4. *Venous thromboembolism in sarcoma patients: a retrospective study. Thierry Alcindor, Ali Al-Fakeeh, K Goulding, Susan Solymoss Nathalie Ste.Marie, Turcotte RE (accepted The Oncologist July 2018 TO-18-081R1)
  5. *Xing S, Freeman CR, Jung S, Turcotte R, Levesque IR. Probabilistic classification of tumour habitats in soft tissue sarcoma. NMR Biomed. 2018 Aug 16:e4000
  6. *Sprague S, Tornetta P 3rd, Slobogean GP, O’Hara NN, McKay P, Petrisor B, Jeray KJ, Schemitsch EH, Sanders D, Bhandari M; FLOW Investigators. Are large clinical trials in orthopaedic trauma justified? BMC Musculoskelet Disord. 2018 Apr 20;19(1):124
  7. *Susan Ge, Yousef Marwan, Abdullah Addar, Nizar Algarni, Eleanor R Chaytor, Robert Turcotte. Arthroscopic Management of Osteoid Osteoma of the Ankle Joint: A Systematic Review of the Literature (accepted The Journal of Foot and Ankle Surgery March 2018)
  8. *Johnathan R Lex, Ahmed Aoude, Jonathan D Stevenson, Nikolaos Stavropoulos, Jay S Wunder, Peter C Ferguson, Scott Evans, Lee Jeys, Krista Goulding, Robert E Turcotte. Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review, Volume 2018 (2018), Article ID 5392785,
  9. * Basamh M, Jarzem P, l Turki, Nahal A, Turcotte RE. Total En Bloc Spondylectomy of T11 Osteosarcoma with Dural Resection: Case Report and Literature Review. International Journal of Neurology and Neurosurgery.10:1. 2018
  10. *Gorelik, N., Reddy S.M.V., Turcotte R.E, Venkatesh SM, Goulding K, Jung S, Alcindor T, Powell TIl. Early Detection of Metastases Using Whole-Body MRI for Initial Staging and Routine Follow-Up of Myxoid Liposarcoma. Skeletal Radiol 2018, 2845-9

 

2017

  1. *Stavropoulos, N.A., Turcotte, R.E., Alsultan, M., Toreson, J. Implant related complications from cemented all-polyethylene tibial component in distal femur endoprostheses. (accepted with revisions to International Orthopaedics Sept 2017 (Manuscript ID INOR-D-17-01135)
  2. * Alraiyes, T.M., Stavropoulos, N.A., Alaseem, A., Jung, S., Turcotte, R.E., Periosteal Aneurysmal Bone Cyst; Clinical Picture. (accepted Lancet Oncology June 2017)
  3. Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D’Adamo DR, Guo M, Chawla S. Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. J Clin Oncol. 2017 Oct 20;35(30):3433-3439
  4. Schur S, Camlioglu E, Jung S, Powell T, Gutman G, Golan J. Preoperative embolization complete tumoral resection of a cervical aggressive epithetlioid osteoblastoma. World Neurosurg. 2017 July12. Pii: S1878-8750(17)31091-4
  5. Tap WD, Papai Z, Van Tine BA, Attia S, Ganjoo K, Jones RL, Schuetze S, Reed D, Chawla SP, Riedel R, Krarup-Hansen A, Bui-Nguyen B, Ray-Coquard I, Hohenberger P, Aglietta M, Cranmer L, Okuno S, Agulnik M, Read, W, Ryan, C, Alcindor T, Garcia del Muro FX, Budd, T, Tawbi, H, Pearce T, Kroll S, Reinke D, Schöffski, P. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced,unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. Lancet Oncology. 2017 Jun 23. pii: S1470-2045(17)30381-9. doi: 10.1016/S1470-2045(17)30381-9. [Epub ahead of print]
  6. * Nooh, A., Goulding, K., Isler, M.H., Mottard, S., Arteau, A., Dion, N., Turcotte, R.E. Surgery For Long Bone Metastases Demonstrates Early And Progressive Improvement In Pain And Functional Outcome But Not Quality Of Life. (accepted CORR April 2017)
  7. *Turcotte, R.E., Stavropoulos, N.A., Toreson, J. Alsultan M.. Radiographic assessment of distal femur cemented stems in tumor endoprostheses. Eur J Orthop Surg Traumatol (2017)
  8. *Davis LA, Dandachli F, Turcotte R, Steinmetz OK. Limb-sparing surgery with vascular reconstruction for malignant lower extremity soft tissue sarcoma.J Vasc Surg. 2017 Jan;65(1):151-156.
  9. *Nooh A, Zhang YL, Sato D, Rosenzweig DH, Tabariès S, Siegel P, Barralet JE and Weber MH. Intra-tumor Delivery of Zoledronate Mitigates Metastasis-induced Osteolysis Superior to Systemic Administration. J Bone Oncol. 2017 Jan 13;6:8-15
  10. *Ahmed Z, Levesque IR. Increased robustness in reference region model analysis of DCE MRI using two-step constrained approaches. Magn Reson Med. 2017 Oct;78(4):1547-1557

 

2016

  1. * Ybarra N, Vallieres M, Jeyaseelan K, Freeman CR, Jung S, Turcotte R, Seuntjens J, El Naqa I. Correlation of Molecular Imaging and Biomarkers Expression in the Prediction of Metastatic Capacity of Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):
  2. Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D’Adamo DR, Guo M, Chawla S. Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis from a Randomized Phase III Study of Eribulin Versus Dacarbazine. Journal of Clinical Oncology. Aug 30:JCO2016716605. doi: 10.1200/JCO.2016.71.6605. [Epub ahead of print]
  3. Ryan CW, Merimsky O, Agulnik M, Blay JY, Schuetze SM, Van Tine BA, Jones RL, Elias AD, Choy E, Alcindor T, Keedy VL, Reed DR, Taub RN, Italiano A, Garcia del Muro X, Judson IR, Buck JY, Lebel F, Lewis JJ, Maki RG, Schöffski P. PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin with or without Palifosfamide in Patients with Metastatic Soft Tissue Sarcoma. Journal of Clinical Oncology. 2016 Sep 12. pii: JCO676684. [Epub ahead of print]
  4. Nuttall J, Evaniew N, Thornley P, Griffin A, Deheshi B, O’Shea T, Wunder J, Ferguson P, Randall RL, Turcotte R, Schneider P, McKay P, Bhandari M, Ghert M. The inter-rater reliability of the diagnosis of surgical site infection in the context of a clinical trial. Bone Joint Res. 2016 Aug;5(8):347-52.
  5. Schneider P, Evaniew N, Rendon JS, McKay P, Randall RL, Turcotte R, Vélez R, Bhandari M, Ghert M; PARITY Investigators. Moving forward through consensus: protocol for a modified Delphi approach to determine the top research priorities in the field of orthopaedic oncology.BMJ Open. 2016 May 24;6(5)
  6. *Stavropoulos N, Sawan H, Dandanchli F, Turcotte R. The use of Ligament Advanced Reinforcement System (LARS®) tube in Stabilization of Proximal Humeral Endoprostheses. World J Orthop, 2016 Apr; 7(4): 265- 271
  7. *Wilmoth M, Freeman, C Quality of Life Outcomes Associated With Reduced Field Image Guided Preoperative Radiotherapy for Primary Soft Tissue Sarcomas of the Extremity: NRG Oncology RTOG 0630. Quality of Life Research (2015 accepted for publication)
  8. *Barbosa Neto O, Garant A, Shakir S, Brossard J, Garde-Granger P, Freeman C. Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity. Cureus. 2016 Jan 1
  9. Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, Wunder JS, Dickson BC, Lundgren SM, Jani KS, De Jay N, Papillon-Cavanagh S, Andrulis IL, Sawyer SL, Grynspan D, Turcotte RE, Nadaf J, Fahiminiyah S, Muir TW, Majewski J, Thompson CB, Chi P, Garcia BA, Allis CD*, Jabado N*, Lewis PW* (2016). Histone H3K36 mutations impair mesenchymal differentiation and promote sarcomagenesis. Science 352(6276):844-849. ISI 33.611
  10. *Nooh A; Turcotte R; Goulding KA. Predictors of Blood Transfusion and Wound Infection Following Surgical Resection of Soft Tissue Sarcoma: Analysis of 788 Patients in ACS-NSQIP Database. Orthopaedic Proceedings 2016 Nov; vol. 98B no.SUPP 20-44.
  11. *Michael D. Bell, Fadi Brimo, Sungmi Jung, Armen G. Aprikian. “Sclerosing Epithelioid Fibrosarcoma Metastasizing to the Penile Shaft: a Case Study”: Canadian Urological Association Journal. 2016 Nov-Dec;10(11-12):E398-E400.
  12. Li XA, Chen X, Zhang Q, Kirsch DG, Petersen I, DeLaney TF, Freeman CR, Trotti A, Hitchcock Y, Bedi M, Haddock M, Salerno K, Dundas G, Wang D. Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results. Pract Radiat Oncol. 2016 Jul-Aug;6(4):e135-40

 

2015

  1. *Skamene S, Abish S, Mitchell D, Freeman C. Radiotherapy is Important for Local Control at Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma. Cureus 2015
  2. Li A, Chen X, Zhang Q, Kirsch D, Petersen I, DeLaney T, Freeman C, Trotti A, Hitchcock Y, Wang D. Margin reduction from IGRT for soft-tissue sarcoma: secondary analysis of RTOG 0630 results. Practical Radiation Oncology 2015:
  3. *Vallières, M., Freeman, C, Skamene, S.R., El Naqa, l. A radiomics model from joint FDG-PET and MR texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Physics in Medicine and Biology 2015;60: 5471 Selected “Editor’s Choice”
  4. *Alcindor T. Response of refractory Ewing sarcoma to pazopanib. (case report) Acta Oncol. 2015 Jul;54(7):1063-4.
  5. The Parity Investigators. Prophylactic antibiotic regimens in tumour surgery (PARITY): a pilot multicentre randomised controlled trial. Bone Joint Res. 2015 Sep;4(9):154-62
  6. *Marwan YA, Abatzoglou S, Esmaeel AA, Alqahtani SM, Alsulaimani SA, Tanzer M, Turcotte RE. Hip arthroscopy for the management of osteoid osteoma of the acetabulum: a systematic review of the literature and case report. BMC Musculoskelet Disord. 2015 Oct 24;16(1)
  7. *Alicia Schiavi, Jacob Lavigne, Robert Turcotte, Lidia Kasprzak, Nadine Dumas, George Chong, Carolyn Freeman, Mona Alameldin, Polymnia Galiatsatos, Laura Palma, William D Foulkes. Using a family history questionnaire to identify patients at high risk for familial sarcoma. Current Onc 2015 Nov 22(5): 317-2
  8. Wang D, Zhang Q, Eisenberg B, Kane J, Li A, Lucas D, Petersen I, DeLaney T, Freeman C, Trotti A, Hitchcock Y, Bedi M, Singh A, Dundas G, Kirsch D. Significant reduction of late toxicities in extremity sarcoma patients treated with image-guided radiotherapy to a reduced target volume. J Clin Oncol. 2015 Feb 9.
  9. Nazarian A, Entezari V, Zurakowski D, Calderon N, Hipp J, Villa-Camacho J, Lin PP, Cheung F, Aboulafia A, Turcotte R, Anderson M, Gebhardt MC, Cheng EY, Terek RM, Yaszemski MJ, Damron T, Snyder B. Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT2 based Rigidity Analysis. Clin Cancer Res. 2015 Jun 1;21(11):2514-9
  10. Chu QS, Nielsen TO, Alcindor T, Gupta A, Endo M, Goytain A, Xu H, Verma S, Tozer R, Knowling M, Bramwell VB, Powers J, Seymour LK, Eisenhauer EA. A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas- ncic-ctg ind 200. Annals of Oncology. 2015 jan

 

2014

  1. Mak IW, Singh S, Turcotte R, Ghert M. The epigenetic regulation of SOX9 by miR-145 in human chondrosarcoma. J Cell Biochem. 2014 Aug 21.
  2. *Baroudi MR, Ferguson PC, Wunder JS, Isler MH, Mottard S, Werier JA, Turcotte RE. Forearm soft tissue sarcoma: Tumors characteristics and oncologic outcomes following limb salvage surgery. J Surg Oncol. 2014 Jun 9.
  3. Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014 Apr;15(4):415-23
  4. *Skamene SR, Rakheja R, Dalhstrom KR, Roberge D, Nahal A, Charest M, Turcotte R, Hickeson M, Freeman C. Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol. 109: 410-414, 2014
  5. *Nguyen NT, Roberge D, Freeman CR, Wong C, Hines J, Turcotte RE. Skin Elasticity as a Measure of Radiation Fibrosis: Is it Reproducible and Does it Correlate with Patient and Physician-reported Measures? Technol Cancer Res Treat. 2013 Aug 31.
  6. Diaz Z, Aguilar-Mahecha A, Paquet ER, Basik M, Orain M, Camlioglu E, Constantin A, Benlimame N, Bachvarov D, Jannot G, Simard MJ, Chabot B, Gologan A, Klinck R, Gagnon-Kugler T, Lespérance B, Samson B, Kavan P, Alcindor T, Dalfen R, Lan C, Chabot C, Buchanan M, Przybytkowski E, Qureshi S, Rousseau C, Spatz A, Têtu B, Batist G. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine. Mod Pathol. 2013 Nov;26(11):1413-24
  7. *Makis W, Rakheja R, Nahal A, Hickeson M, Lisbona R. Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT. Clin Nucl Med. 2013 May;38(5):e218-2
  8. *Rakheja R, Makis W, Tulbah R, Skamene S, Holcroft C, Nahal A, Turcotte R, Hickeson M. Necrosis on FDG PET/CT Correlates With Prognosis and Mortality in Sarcomas. AJR Am J Roentgenol. 2013 Jul;201(1):170-7.
  9. Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, DeLaney T, Abrams R, Indelicato D, Baldini E, Hitchcock Y, Kirsh DG, Kozak KR, Wolfson A, Wang D. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. International Journal of Radiation Oncology Biology and Physics 2013; 86:298-303
  10. *Garg A, Nahal A, Turcotte R, Tabah R, Alcindor T. Primitive neuroectodermal tumor (PNET) as somatic-type malignancy arising from an extragonadal germ-cell tumor: Clinical, pathological and molecular features of a case. Tumori. 2013 Jan-Feb;99(1):24e- 7e.
  11. *Alsulaimani SA, Turcotte RE; The Canadian Orthopaedic Oncology Society (CANOOS) collaborators. Iterative Curettage is Associated with Local Control in Giant Cell Tumors involving the Distal Tibia. Clin Orthop Relat Res. 2013 Apr 9. [Epub ahead of print]
  12. Pazionis TJ, Alradwan H, Deheshi BM, Turcotte R, Farrokyhar F, Ghert M. A Systematic Review and Meta-Analysis of En-Bloc vs Intralesional Resection for Giant Cell Tumor of Bone of the Distal Radius. Open Orthop J. 2013 Apr 28;7:103-8.
  13. Demetri GD, Chawla SP, Ray-Coquard I, Le Cesne A, Staddon AP, Milhem MM, Penel N, Riedel RF, Bui-Nguyen B, Cranmer LD, Reichardt P, Bompas E, Alcindor T, Rushing D, Song Y, Lee RM, Ebbinghaus S, Eid JE, Loewy JW, Haluska FG, Dodion PF, Blay JY. Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy. J Clin Oncol. 2013 Jul 1;31(19):2485-92
  14. Mak Isabella W. Y., Turcotte RE, Ghert M. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells. Bone. 2013 Mar 2.
  15. *Vakilian S, Freeman CR, Al-Suhaibani A, Roberge D. Kinetics of myxoid liposarcoma radiation response and effects on radiation dose delivery. Practical Radiation Oncology 2013; 3:180-185
  16. *Amit Garg, Ayoub Nahal, Robert Turcotte, Roger Tabah, Thierry Alcindor. Primitive Neuroectodermal Tumor (PNET) Primitive neuroectodermal tumor (PNET) as somatic-type malignancy arising from an extragonadal germ-cell tumor: clinical, pathological and molecular features of a case. Tumori 2013; 99(1): e24 – e27
  17. *Vakilian S, Freeman CR, Al-Suhaibani A, Roberge D. Kinetics of myxoid liposarcoma radiation response and effects on radiation dose delivery. Practical Radiation Oncology 2013; 3:180-185

 

2012

  1. Ghert M, Deheshi B, Holt G, Randall RL, Ferguson P, Wunder J, Turcotte R, Werier J, Clarkson P, Damron T, Benevenia J, Anderson M, Gebhardt M, Isler M, Mottard S, Healey J, Evaniew N, Racano A, Sprague S, Swinton M, Bryant D, Thabane L, Guyatt G,Bhandari M; The PARITY Investigators. Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study. BMJ Open. 2012 Nov 8;2(6). 41. *Roberge D, Vakilian S, Alabed YZ, Turcotte RE, Freeman CR, Hickeson M. FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma. Sarcoma. 2012
  2. *Abu-sanad A, Warsi A, Michel RP, Nahal A, Popradi G, Storring JM, Liberman AS, Alcindor T. Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma. Current Oncology. 2012 aug; 19(4):e289-91.
  3. *Makis W, Alabed YZ, Nahal A, Novales-Diaz JA, Hickeson M. Giant Cell Tumor Pulmonary Metastases Mimic Primary Malignant Pulmonary Nodules on (18)F-FDG PET/CT. Nucl Med Mol Imaging. 2012 Jun;46(2):134-7
  4. Singh S, Singh M, Mak IWY, Turcotte R, Ghert M (2012) Investigation of FGFR2-IIIC Signaling via FGF-2 Ligand for Advancing GCT Stromal Cell Differentiation. PLoS ONE 7(10): e46769.
  5. *Desy NM, Bernstein M, Nahal A, Aziz M, Kenan S, Turcotte RE, Kahn LB. Primary perivascular epithelioid cell neoplasm (PEComa) of bone: Report of two cases and review of the literature. Skeletal Radiol. 2012 Jul 3
  6. *Trabulsi NH, Patakfalvi L, Nassif MO, Turcotte RE, Nichols A, Meguerditchian AN. Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: Systematic review of clinical efficacy and quality assessment of reported trials. J Surg Oncol. 2012 Jul 17.
  7. *Rakheja R, Makis W, Skamene S, Nahal A, Brimo F, Azoulay L, Assayag J, Turcotte R, Hickeson M. Correlating Metabolic Activity on 18F-FDG PET/CT With Histopathologic Characteristics of Osseous and Soft-Tissue Sarcomas: A Retrospective Review of 136 Patients. AJR Am J Roentgenol. 2012 Jun;198(6):1409-16
  8. Mak IW, Turcotte RE, Ghert M. Transcriptomic & proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein (PTHrP) regulation of the cell cycle and apoptosis. Bone Miner Res. 2012 Apr 16.
  9. Riad S, Biau D, Holt GE, Werier J, Turcotte RE, Ferguson PC, Griffin AM, Chung PW, Catton CN, O’Sullivan B, Wunder JS. The Clinical and Functional Outcome for Patients with Radiation-Induced Soft-Tissue Sarcoma. Cancer. 2012;118(10):2682-92
  10. Rakheja R, Nahal A, Charest M, Brimo F, Skamene S, Azoulay L, Assayag J, Hickeson M. Metabolic activity measured by SUV from FDG-PET scans as a predictor of histopathologic characteristics: A retrospective review of 136 patients with sarcoma. Am J Roentgenol, 198: 1409-1416, 2012.
  11. *Trabulsi NH, Patakfalvi L, Nassif MO, Turcotte RE, Nichols A, Meguerditchian AN. Hyperthermic Isolated Limb Perfusion for Extremity Soft Tissue Sarcomas: Systematic Review of Clinical Efficacy and Quality Assessment of Reported Trials. Journal of Surgical Oncology 2012 December 106 (8): 921-928.

 

2011

  1. * Friedmann, D., Wunder, J., Ferguson, P.C., O’Sullivan, B., Roberge, D., Catton, C.N., Freeman, C., Saran, N., and Turcotte, R.. Incidence and severity of lymphoedema following limb salvage of extremity soft tissue sarcoma. Sarcoma, 2011, 6
  2. *Moreau LC, Turcotte R, Ferguson P, Wunder J, Clarkson P, Masri B, Isler M, Dion N, Werier J, Ghert M, Deheshi B; the Canadian Orthopaedic Oncology Society (CANOOS). Myxoid\Round Cell Liposarcoma (MRCLS) Revisited: An analysis of 418 primarily Managed Cases. Ann Surg Oncol. Vol 19:4 2012, Page 1081-1088
  3. *Hanna WC, Ferri LE, McKendy KM, Turcotte RE, Sirois C, Mulder DS. Reconstruction after major chest wall resection: Can rigid fixation be avoided? Surgery 2011;150(4):590-7.
  4. Biau DJ, Ferguson PC, Turcotte RE, Chung P, Isler MH, Riad S, Griffin AM, Catton CN, O’Sullivan B, Wunder JS. Adverse effect of age on the recurrence of soft tissue sarcoma of the extremity and trunk. J Clin Oncol. 2011 Oct 20;29(30):4029-35
  5. *Yoon J, Al Shafai L, Nahal A, Turcotte RE, Martin MH. Melorheostosis of the sacrum causing acute-onset neurological symptoms. Skeletal Radiol. 2011 Jun 12
  6. Mak IW, Cowan RW, Turcotte RE, Singh G, Ghert M. PTHrP Induces Autocrine/Paracrine Proliferation of Bone Tumor Cells through Inhibition of Apoptosis. PLoS One. 011;6(5):e19975.
  7. Singh S, Mak I, Cowan RW, Turcotte R, Singh G, Ghert M. The role of TWIST as a regulator in giant cell tumor of bone. J Cell Biochem. 2011 Sep;112(9):2287-95.
  8. *Roberge D, Skamene T, Turcotte RE, Powell T, Saran N, Freeman C. Inter- and intra-observer variation in soft-tissue sarcoma target definition. Cancer Radiother. 2011;15(5):421-5.
  9. Mak IW, Turcotte RE, Popovic S, Singh G, Ghert M. AP-1 as a regulator of MMP-13 in the stromal cell of Giant Cell Tumor of Bone. Biochem Res Int. 2011;2011:164197.
  10. *Makis W, Ciarallo A, Hickeson M. Malignant extrarenal rhabdoid tumor of the spine: staging and evaluation of response to therapy with F-18 FDG PET/CT. Clin Nucl Med. 2011 Jul;36(7):599-602
  11. Hickey M, Farrokhyar F, Deheshi B, Turcotte R, Ghert M. A systematic review and meta-analysis of intralesional vs. wide resection for low-grade intramedullary chondrosarcoma. Ann Surg Oncol. 2011 Jun;18(6):1705-9.
  12. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH, DeLaney TF. RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81
  13. *Makis W, Ciarallo A, Hickeson M, Derbekyan V. Angiomatoid fibrous histiocytoma: staging and evaluation of response to therapy with F-18 FDG PET/CT. Clin Nucl Med. 2011 May;36(5):376-9.
  14. *Friedmann D, Wunder J, Ferguson P, O’Sullivan B, Roberge D, Catton C, Freeman C, Saran N, Turcotte R. Incidence and severity of lymphedema following limb salvage of extremity soft tissue sarcoma. Sarcoma 2011; epub ahead of print
  15. *Saran N, Turcotte RE, Zhang R. Osteogenic Protein-1 Delivered by Hydroxyapatite-coated Implants Improves Bone Ingrowth in Extracortical Bone Bridging. Clin Orthop Relat Res. 2011 May;469(5):1470-8.
  16. Rakheja R, Makis W, Nahal A, Alabed YZ, Abikhzer G, Probst S, Hickeson M. Round Cell Liposarcoma Presenting as an FDG-Positive Primary With an FDG-Negative Retroperitoneal Metastasis: A Pitfall for F-18 FDG PET/CT Imaging. Clin Nucl Med. 36: e213-e216, 2011.

 

2010

  1. *Roberge D, Hickeson M, Charest M, Turcotte RE. Initial McGill experience with fluorodeoxyglucose pet/ct staging of soft-tissue sarcoma. Curr Oncol. 2010 Nov;17(6):18-22.
  2. *Ajlan A, Turcotte R, Alcindor T, Nahal A: Dedifferentiated giant cell tumor of bone in the form of low-grade fibroblastic osteogenic sarcoma. A case report of a unique presentation with follow-up. Current Oncology. 2010 Aug; 17 (4): 71-76
  3. *Roberge D, Skamene T, Nahal A, Turcotte RE, Powell T, Freeman C. Radiological and Pathological Response Following Pre-operative Radiotherapy for Soft-tissue Sarcoma. Radiother Oncol. 2010 Dec;97(3):404-7. 71. Singh S, Mak I, Power P, Cunnigham M, Turcotte R, Ghert M Gene transfection in primary stem-like cells of giant cell tumor of bone. Stem Cells Cloning. 2010 Sep 28;3:129-34.
  4. Gortzak, R. Kandel, B. Deheshi, J. Werier, R. E. Turcotte, P. C. Ferguson, and J. S. Wunder. The efficacy of chemical adjuvants on giant-cell tumour of bone: An in vitro study. J Bone Joint Surg Br 2010 92-B: 1475-9.
  5. *Makis W, Novales-Diaz JA, Hickeson M. Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT. Clin Nucl Med. 2010 Jul;35(7):517-20
  6. *D Latt, RE Turcotte, MH Isler, C Wong. Soft tissue sarcoma of the foot. Can J Surg. 2010 Dec;53(6):424-31.
  7. *Ajlan AM, Sayegh K, Powell T, David H, Riha RM, Khan J, Nahal A. Angiomatoid fibrous histiocytoma: magnetic resonance imaging appearance in 2 cases. J Comput Assist Tomogr. 2010 Sep-Oct;34(5):791-4
  8. *Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D. Local Recurrence After Initial Multidisciplinary Management of Soft Tissue Sarcoma: Is There a Way Out? Clin Orthop Relat Res. 2010 Nov;468(11):3012-8.
  9. *Nahal A, Ajlan A, T Alcindor, R Turcotte, Dedifferentiated giant cell tumor of bone in the form of low grade fibroblastic osteogenic sarcoma. Curr Oncol. 2010 Aug;17(4):71-6.
  10. *Makis W, Hickeson M. Spindle cell sarcoma degeneration of giant cell tumor of the knee, imaged with F-18 FDG PET-CT and Tc-99m MDP bone scan. Clin Nucl Med. 2010 Feb;35(2):112-5
  11. Algawahmed H, Turcotte R, Farrokhyar F, Ghert M: High-Speed Burring with and without the Use of Surgical Adjuvants in the Intralesional Management of Giant Cell Tumor of Bone: A Systematic Review and Meta-Analysis. Sarcoma 2010, 2010.
  12. Mak IWY, Seidlitz EP, Cowan RW, Turcotte RE, Popovic S, Wu WCH, Singh G, Ghert M: Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone. Human Pathology 2010, 41(9):1320-1329.
  13. *Makis W, Hickeson M, Lisbona R. Interesting image. Maffucci syndrome with extraosseous chondrosarcoma imaged with F-18 FDG PET-CT. Clin Nucl Med. 2010 Jan;35(1):29-31
  14. *Makis W, Novales-Diaz JA, Hickeson M. Primary Thyroid Osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT. Clin Nucl Med. 35: 517-520, 2010.
  15. *Makis W, Hickeson M, Derbekyan V. Myeloid Sarcoma presenting as an anterior mediastinal mass invading the pericardium: serial imaging with F-18 FDG PET-CT. Clin Nucl Med. 35: 706-709, 2010. 84. *Roberge D, Hickeson M, Charest M, Turcotte RE. Initial McGill experience with fluorodeoxyglucose PET/CT staging of soft-tissue sarcoma. Curr Oncol. 17: 18-22, 2010.
  16. *Najarian D, Morrison C, Sait SN, Meguerditchian AN, Kane JM, Cheney R, Zeitouni NC. Recurrent Giant Cell Fibroblastoma Treated with Mohs Micrographic Surgery. Dermatologic Surgery. Dermatologic Surgery 2010 March 36 (3) 417-421.
  17. *Meguerditchian AN, Wang J, Lema B, Lopian S, Kraybill WG, Zeitouni NC, Kane JM. Wide Excision or Mohs Micrographic Surgery for the Treatment of Primary Dermatofibrosarcoma Protuberans. American Journal of Clinical Oncology 2010; June 33 (3) 300-303.

 

2009

  1. Rabinovich A, Mak IW, Cowan RW, Turcotte RE, Colterjohn N, Singh G, Ghert M. Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone. Open Bone J. 2009 Fall;1:46-52.
  2. * Charest M, Hickeson M, Lisbona R, Novales JA, Derbekyan V, Turcotte RE FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases..Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1944-51.
  3. Davidge K, Bell RS, Ferguson P, Turcotte RE, Wunder J, Davis A.M. Patient Expectations for Surgical Outcome in Extremity Soft Tissue Sarcoma. J Surg Oncol. 2009;100:375–381
  4. *Karam I., Devic S., Hickeson M., Roberge D., Turcotte RE, Freeman CR. PET/CT for Radiotherapy Treatment Planning in Patients with Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys. 2009; 75(3): 817–821.
  5. *Al Ghamdi A, Hings I, Turcotte RE, The management of bone metastases; A surgical perspective. Aging Health, June 2009, Vol. 5, No. 3, Pages 313-321.
  6. *Turcotte RE, Ferrone M, Isler MH, Wong C, Soft tissue sarcoma of the popliteal fossea. Can J Surg, 2009 Feb;52(1):51-55.
  7. *Nahal A. and Meterissian S 2009 Lipoleiomyosarcoma of the rectosigmoid colon: a unique site for a rare variant of liposarcoma American Journal of Clinical Oncology 32:353-5

 

2008

  1. Al-Otaibi M, Turcotte RE, Hings I, Beaudet J, Isler M, Nahal A , Wong C. Low dose chemotherapy for extra-abdominal desmoid tumors, Saudi Medical Journal 2008; Vol. 29 (12): 1730-1734
  2. *Brimo F., Dion D., Huwait H., Turcotte R.E., Nahal A. The Utility of MDM2 and CDK4 Immunostains in Needle Biopsy Interpretation of Lipomatous Tumors: A Study of 21 Tru-Cut Biopsy Cases. Histopathology. 2008 Jun;52(7):892-5.
  3. *Charest M, Singnurkar A, Hickeson M, Novales JA, Derbekyan V. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging. Clin Nucl Med. 2008 Jul;33(7):455-8.
  4. *Dickson BC., Li SQ., Wunder J., Ferguson P., Eslami B., Werier J., Turcotte R., Kandel R. Giant Cell Tumors of Bone Express p63. Mod Pathol. 2008 Apr;21(4):369-75.